Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Myelodysplasias

Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings

Leukemia volume 27, pages 604–609 (2013)Cite this article

Subjects

Abstract

We investigated whether a young human leukocyte antigen (HLA)-matched unrelated donor (MUD) should be preferred as donor to an HLA-identical sibling (MRD) for older patients with myelodysplastic syndrome (MDS) (⩾50 years) who underwent allogeneic stem cell transplantation (AHSCT). Outcomes of 719 MDS patients with a median age of 58 years (range, 50–73 years) who received AHSCT from related (n=555) or unrelated (n=164) donors between 1999 and 2008 and reported to the European Group for Blood and Marrow Transplantation were analyzed. The median donor age of the MRD was 56 years (range: 35–78), in contrast to 34 years (range: 19–64) for the MUDs. Influence of donor’s age on survival was not observed for MRD (hazard ratio (HR): 1.01 (95% confidence interval (CI): 0.99–1.02), P=0.2), but there was a significant impact of MUD’s age on outcome (HR: 1.03 (95% CI: 1.01–1.06); P=0.02). Transplantation from younger MUDs (<30 years) had a significant improved 5-year overall survival in comparison with MRD and older MUDs (>30 years): 40% vs 33% vs 24% (P=0.04). In a multivariate analysis, AHSCT from young MUD (<30 years) remained a significant factor for improved survival in comparison with MRD (HR: 0.65 (95% CI: 0.45–0.95), P=0.03), which should be considered in donor selection for older patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Anderson JE, Anasetti C, Appelbaum FR, Schoch G, Gooley TA, Hansen JA et al. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. Br J Haematol 1996; 93: 59–67.

    Article  CAS  Google Scholar 

  2. Castro-Malaspina H, Harris RE, Gajewski J, Ramsay N, Collins R, Dharan B et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood 2002; 99: 1943–1951.

    Article  CAS  Google Scholar 

  3. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Pérez WS, Anasetti C et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 2004; 104: 579–585.

    Article  CAS  Google Scholar 

  4. de Witte T, Hermans J, Vossen J, Bacigalupo A, Meloni G, Jacobsen N et al. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2000; 110: 620–630.

    Article  CAS  Google Scholar 

  5. Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J et al. for the Myelodysplastic Syndrome subcommittee of the Chronic Leukemia Working Party of the European Blood and Marrow Transplantation Group. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood 2006; 108: 836–846.

    Article  CAS  Google Scholar 

  6. Lim Z, Brand R, Martino R, van Biezen A, Finke J, Bacigalupo A et al. Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia. J Clin Oncol 2010; 28: 405–411.

    Article  Google Scholar 

  7. Ho AY, Pagliuca A, Kenyon M, Parker JE, Mijovic A, Devereux S et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning. Blood 2004; 104: 1616–1623.

    Article  CAS  Google Scholar 

  8. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043–2051.

    Article  CAS  Google Scholar 

  9. Carreras E, Jiménez M, Gómez-García V, de la Cámara R, Martín C, Martínez F et al. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 2006; 37: 33–40.

    Article  CAS  Google Scholar 

  10. Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant 1991; 7: 443–452.

    CAS  PubMed  Google Scholar 

  11. Kröger N . Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome. Blood 2012; 119: 5632–5639.

    Article  Google Scholar 

  12. Guardiola P, Runde V, Bacigalupo A, Ruutu T, Locatelli F, Boogaerts MA et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 2002; 99: 4370–4378.

    Article  CAS  Google Scholar 

  13. Miller RA . The aging immune system: primer and prospectus. Science 1996; 273: 70–74.

    Article  CAS  Google Scholar 

  14. Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood 2000; 96: 4096–4102.

    CAS  PubMed  Google Scholar 

  15. Schultz KR, Green GJ, Wensley D, Sargent MA, Magee JF, Spinelli JJ et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994; 84: 3212–3220.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    N Kröger, T Zabelina & H Alchalby

  2. Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands

    L de Wreede & A van Biezen

  3. Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    J Berger

  4. CHU Bordeaux, Hopital Haut-leveque, Pessac, France

    N Milpied

  5. Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

    L Volin

  6. Department of Hematology, CHU Nantes, Nantes, France

    M Mohty

  7. Department of Hematology, Groupe Hospitalier Pitié-Salpetriere, Paris, France

    V Leblond

  8. Unité de transplantation et thérapie cellulaire, Institut Paoli Calmettes, Marseille, France

    D Blaise

  9. Department of Medicine-Hematology and Oncology, University of Freiburg, Freiburg, Germany

    J Finke

  10. Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands

    N Schaap

  11. Department of Hematology-BMT, Hopital St Louis, Paris, France

    M Robin

  12. Department of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands

    T de Witte

Authors
  1. N Kröger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Zabelina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L de Wreede
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Alchalby
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A van Biezen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N Milpied
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L Volin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Mohty
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. V Leblond
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D Blaise
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J Finke
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. N Schaap
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. M Robin
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. T de Witte
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the MDS subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Corresponding author

Correspondence to N Kröger.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Author contributions

NK designed the study, analyzed, interpreted data and wrote the manuscript. TZ, LdW and JB performed statistical analysis, HA and AvB collected patients data. NM, LV, MM, VL, DB, JF, NS, MR contributed patients data. TdW wrote the manuscript. All authors approved the final version of the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kröger, N., Zabelina, T., de Wreede, L. et al. Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings. Leukemia 27, 604–609 (2013). https://doi.org/10.1038/leu.2012.210

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.210

Keywords

This article is cited by

Search

Advanced search

Quick links